Steven M. Keller

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

Heather A. Wakelee, Moïshe Liberman, Terufumi Kato et al. · New England Journal of Medicine · 2023 · 903 citations · Full text

Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial

Mary O’Brien, Luis Paz‐Ares, Sandrine Marréaud et al. · The Lancet Oncology · 2022 · 696 citations

Interim Analysis, Surgical Oncology, Oncology +8

A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung Cancer

Steven M. Keller, Sudeshna Adak, Henry Wagner et al. · New England Journal of Medicine · 2000 · 450 citations · Full text

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer

Steven M. Keller, Sudeshna Adak, Henry Wagner et al. · The Annals of Thoracic Surgery · 2000 · 345 citations · Full text

Medicine, Multiple Pulmonary Nodule, Pathology +6

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer

Salma K. Jabbour, Ki Hyeong Lee, Nikolaj Frost et al. · JAMA Oncology · 2021 · 231 citations · Full text